Ovarian cancer's specific scent detected by dogs

Ground-breaking research in the June issue of Integrative Cancer Therapies published by SAGE explored whether ovarian cancer has a scent different from other cancers and whether working dogs could be taught to distinguish it in its different stages.

Ovarian cancer has a high mortality rate, primarily due to late diagnosis. Recent studies have shown that dogs have successfully detected cancer through scent, however, it's not clear whether they're responding to the cancer itself or odors associated with cancer.

The researchers, led by György Horvath MD, PhD, from the University Hospital in Göteborg, Sweden, along with colleagues at Working Dog Clubs in Sweden and Hungary, trained dogs to distinguish different types and grades of ovarian cancer, including borderline tumors. They found that the odor of ovarian cancer does seem to differ from those of other gynecological malignancies, such as cervical, or endometrial cancers, suggesting that a particular, distinguishable scent is associated with ovarian cancer. They additionally found that early-stage and low grade ovarian cancers emit the same scent as advanced tumors.

"Our study strongly suggests that the most common ovarian carcinomas are characterized by a single specific odor detectable by trained dogs," write the authors in the article. "And while we do not believe that dogs should be used in clinical practice, because they may be influenced during their work, leading to changes in the accuracy rates, still, under controlled circumstances, they may be used in experiments to further explore this very interesting new property of malignancies."

Adds Keith I. Block, MD, editor-in-chief of Integrative Cancer Therapies, "I believe there is great value in this study, which adds to the growing body of research suggesting the diagnostic skills of these specially trained dogs. Their ability to detect specific odors associated with chemicals related to malignancy should eventually lead to effective methods and tools for very early detection, and thus a greater proportion of cancer cures!"

Source: SAGE Publications

Related stories:

Net widens as more proteins implicated in cancer spread
(PhysOrg.com) -- Authorities are on the lookout for 64 proteins believed to have been talking to well-known cancer kingpin urokinase plasminogen activator receptor (a.k.a uPAR).
Disease diagnosis in just 15 minutes
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
Bio-imaging mass spectrometry techniques reveal molecular details about complex systems
Understanding biology at the systems level is difficult, especially when studying complex specimens like tissue slices or communities of organisms in a biofilm. Scientists must be able to identify, quantify and locate the molecules present in the samples.
New approach to gene therapy may shrink brain tumors, prevent their spread
Massachusetts General Hospital (MGH) researchers are investigating a new approach to gene therapy for brain tumors – delivering a cancer-fighting gene to normal brain tissue around the tumor to keep it from spreading. An animal study published in the journal Molecular Therapy, the first to test the feasibility of such an approach, found that inducing mouse brain cells to secrete human interferon-beta suppressed and eliminated growth of human glioblastoma cells implanted nearby.
Scientists identify novel inhibitor of human microRNA
Scientists at The Wistar Institute and their colleagues have identified, for the first time, a molecule that can regulate microRNAs – short strands of RNA that play a vital role in gene expression and are closely associated with cancer. The discovery points the way to the development of a new generation of cancer drugs.
Vascular marker of ovarian cancer identified
Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth, a finding that could aid in diagnosis and treatment of ovarian cancer.
Scientists deliver toxic genes to effectively kill pancreatic cancer cells
A research team, led by investigators at the Department of Surgery at Jefferson Medical College of Thomas Jefferson University and the Kimmel Cancer Center at Jefferson, has achieved a substantial "kill" of pancreatic cancer cells by using nanoparticles to successfully deliver a deadly diphtheria toxin gene. The findings – set to be published in the October issue of Cancer Biology & Therapy – reflect the first time this unique strategy has been tested in pancreatic cancer cells, and the success seen offers promise for future pre-clinical animal studies, and possibly, a new clinical approach.
Ovarian cancer test is under fire
OvaSure, the much bally­hooed new diagnostic blood test for early detection of ovarian cancer, is still causing much consternation.

News discussion:

Medicine & Health news